ZIM Laboratories Limited (NSE:ZIMLAB)
99.50
-0.66 (-0.66%)
May 25, 2026, 9:26 AM IST
ZIM Laboratories Revenue
In the fiscal year ending March 31, 2026, ZIM Laboratories had annual revenue of 3.74B INR, down -1.25%. ZIM Laboratories had revenue of 1.05B in the quarter ending March 31, 2026, a decrease of -3.27%.
Revenue
3.74B
Revenue Growth
-1.25%
P/S Ratio
1.43
Revenue / Employee
6.49M
Employees
577
Market Cap
5.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.74B | -47.33M | -1.25% |
| Mar 31, 2025 | 3.79B | 116.16M | 3.16% |
| Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
| Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
| Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Nectar Lifesciences | 16.70B |
| Windlas Biotech | 9.22B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.96B |
| Jagsonpal Pharmaceuticals | 2.87B |
| Sakar Healthcare | 2.54B |
ZIM Laboratories News
- 2 months ago - Q2 2026 ZIM Laboratories Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Zim Laboratories Ltd (BOM:541400) Q3 2026 Earnings Call Highlights: Strong Export Growth Amid ... - GuruFocus
- 3 months ago - Q3 2026 ZIM Laboratories Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 10 months ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 10 months ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn